Fundz

Sihuan Pharmaceutical（0460.Hk）: Huisheng Biopharmaceutical Successfully Completed The A + Round Of Financing

PRIVATEJan 04, 2023

Round Type

Funding Round

ChinaBiotechnologyPharmaceuticalBiopharma

Description

Sihuan Pharmaceutical Holdings Group Co., Ltd. (the "Company" or "Sihuan Pharmaceutical", together with its subsidiaries, collectively referred to as the "Group"; stock code: 0460) is pleased to announce that the Group's Jilin Huisheng Biopharmaceutical Co., Ltd. ("Huisheng Biopharmaceutical"), a non-wholly owned subsidiary, has successfully completed the acquisition of Jilin Baixing Bairong Investment Center (Limited Partnership)* ("Baixing Bairong"), JiLin Province Private Equity Co., Ltd. ("JLPE"), Jilin Province Technology Investment Fund Co., Ltd

Quick answer

Sihuan Pharmaceutical Holdings Group raised an undisclosed amount in a Funding Round round, dated January 4, 2023. Sihuan Pharmaceutical Holdings Group is based in China.

How much did Sihuan Pharmaceutical Holdings Group raise?
Sihuan Pharmaceutical Holdings Group raised an undisclosed amount in a Funding Round round on January 4, 2023.
What does Sihuan Pharmaceutical Holdings Group do?
In 2001, the establishment of Hainan Sihuan Pharmaceutical Co., Ltd. marked the starting point of Sihuan Pharmaceutical Holding Group's entrepreneurial development.
Where is Sihuan Pharmaceutical Holdings Group based and how big is it?
Sihuan Pharmaceutical Holdings Group is based in China.

Source: Fundz verified event record.

Who else raised in Pharmaceutical and Biopharma around the same time

Companies in the same sectors as Sihuan Pharmaceutical Holdings Group that raised within 45 days of this round, from Fundz verified event records.

  • Disc raised $63M (Funding Round) on February 14, 2023.
  • Provention Bio raised $35M on February 13, 2023.
  • Biodexa Pharmaceuticals raised $6M on February 9, 2023.
  • CUREMARK LLC raised $1.3M (Seed) on January 30, 2023.
  • HighTide Therapeutics raised $107M (Series C) on January 5, 2023.
  • Madrigal Pharmaceuticals raised $300M (Funding Round) on December 21, 2022.

Who to call at Sihuan Pharmaceutical Holdings Group, and when

A new round usually means Sihuan Pharmaceutical Holdings Group is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Sihuan Pharmaceutical Holdings Group raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Sihuan Pharmaceutical Holdings Group, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Sihuan Pharmaceutical Holdings Group. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Sihuan Pharmaceutical Holdings Group

Location

China

About

In 2001, the establishment of Hainan Sihuan Pharmaceutical Co., Ltd. marked the starting point of Sihuan Pharmaceutical Holding Group's entrepreneurial development. At the beginning of the company's establishment, marketing was the forerunner, and then Hainan Sihuan Cardiovascular and Cerebrovascular Drug Research Institute was established, so that market development and new product research and development went hand in hand, and the company developed rapidly. Afterwards, capital operation methods such as acquisitions and mergers were used to further improve the industrial chain, and companies such as Beijing Sihuan Pharmaceutical and Shenzhen Sihuan Pharmaceutical were successively incorporated into Sihuan Pharmaceutical, and developed into a group pharmaceutical enterprise integrating R&D, production and sales. In April 2006, Sihuan Pharmaceutical Holdings Group was incorporated in Bermuda and successfully listed in Singapore in March 2007. In 2009, in order to meet the needs of greater development, Sihuan Pharmaceutical Holdings Group completed its privatization and delisted from Singapore. In 2010, it was successfully listed again on the main board of Hong Kong. So far, Sihuan Pharmaceutical Holdings Group has strong research and development capabilities, high-quality product structure, and a complete production management system. With a unique marketing model and professional services, it has deeply cultivated the Chinese cardiovascular and cerebrovascular drug market and served human health. , has won wide acclaim from all walks of life and expert users, and established a professional brand image of "Sihuan"

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Sihuan Pharmaceutical Holdings Group raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Sihuan Pharmaceutical Holdings Group's next move

See what Strategic adds

Sihuan Pharmaceutical Holdings Group raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.